EUVIMEDEUVIMED entdecken
Crossref

Management of adverse events post-COVID-19 vaccination with Covaxin and Covishield

Ayush Kumar, Shweta Shrivastava, Prashant Tiwari

One Health Bulletin · 2022

DOI: 10.4103/2773-0344.347378 ↗

Kurz gefasst

Fachartikel in der Zeitschrift One Health Bulletin, 2022. Verfasst von Ayush Kumar und 2 weiteren Autor:innen. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 16 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Covaxin and Covishield have been granted approval for emergency medical use in India due to the severity of COVID-19. Both vaccines are safe and effective and have a good immunogenic response. There is no difference between Covaxin and Covishield in terms of dosages and both can be administered as 0.5 mL (containing 6 mg of virus antigen for Covaxin and 5×10 10 virus particles for Covishield) in the upper arm region. Covaxin and Covishield are designed for a two dose schedule, and it is advised that the second dose of Covaxin be administered 4-6 weeks after the first dose while 12-16 weeks after the first dose for Covishield. These vaccines may have several side effects such as swelling and itching at the injection site, joint pain, dizziness, headache, allergic reaction, increased heartbeat, and fever. Appropriate counselling and suggestion should be provided for any symptoms associated with vaccination so that post-vaccinated issues can be managed. Physician and community pharmacists may play a vital role in the management of adverse drug event associated with vaccines.

Zitieren

APA

Kumar, A., Shrivastava, S., & Tiwari, P. (2022). Management of adverse events post-COVID-19 vaccination with Covaxin and Covishield. One Health Bulletin. https://doi.org/10.4103/2773-0344.347378

Vancouver

Kumar A, Shrivastava S, Tiwari P. Management of adverse events post-COVID-19 vaccination with Covaxin and Covishield. One Health Bulletin. 2022. doi:10.4103/2773-0344.347378

BibTeX
@article{Kumar2022,
  author = {Kumar, Ayush and Shrivastava, Shweta and Tiwari, Prashant},
  title = {Management of adverse events post-COVID-19 vaccination with Covaxin and Covishield},
  journal = {One Health Bulletin},
  year = {2022},
  doi = {10.4103/2773-0344.347378}
}
Kostenlos starten →